超越MEP路径:一种新的激酶,需要用于疟疾寄生虫的先利用
Marcell Crispim1,2, Ignasi Bofill Verdaguer1, Agustín Hernández3
1Department of Parasitology, Institute of Biomedical Sciences of the University of São Paulo, São Paulo, Brazil.
PLoS pathogens
|January 26, 2024
概括
研究人员在疟疾寄生虫中发现了一种新的prenol救援途径,涉及prenol激酶 (PolK) 酶. 这一途径允许寄生虫在自己的合成被阻止时使用食前,从而影响药物耐药性.
科学领域:
- 生物化学 生物化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 甲基四酸盐 (MEP) 途径对于疟疾寄生虫的生存至关重要,产生关键代谢物,如法纳西尔酸盐 (FPP) 和日拉尼尔日拉尼尔酸盐 (GGPP).
- 像米素这样的MEP途径抑制剂是潜在的抗疟疾药物,但寄生虫耐药性可能会出现.
- 食前醇 (法内索尔和日拉尼尔日拉尼奥尔) 可以从MEP抑制剂中拯救寄生虫,这表明一种潜在的救援途径.
研究的目的:
- 为了识别和描述在Plasmodium falciparum中负责先救援的酶.
- 调查这种先救援途径在疟疾寄生虫生存能力和药物易感性中的生物学意义.
主要方法:
- 全基因组的基因识别和特征的跨膜前激酶 (PolK).
- 在Saccharomyces cerevisiae中对PolK的异质表达,用于功能验证酶活性.
- 创造和分析条件淘汰赛 (Δ-PolK) P. falciparum寄生虫.
主要成果:
- 发现了一种新型的P. falciparum编码跨膜前激酶 (PolK) 的基因,并证实了其法纳索尔/格拉尼尔格拉尼奥尔激酶活性.
- Δ-PolK 寄生虫对米多辛的敏感性增加,并且无法通过先来挽救,这表明该途径的重要性.
- Δ-PolK寄生虫失去了使用prenols用于蛋白质prenylation的能力,发现人体血含有geranylgeraniol (GGOH).
结论:
- 已确定的FOH/GGOH救援途径为疟疾寄生虫提供了异oprenoids 的替代来源,当 de novo 生物合成被抑制时.
- 聚基是这种救援途径中的关键酶,为抗疟疾药物开发提供了潜在的新目标.
- 了解这种途径对于克服耐药性和开发更有效的疟疾治疗方法至关重要.
相关概念视频
01:07MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
02:15M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K